Phocas Financial Corp’s Avanos Medical AVNS Stock Holding History

Phocas Financial Corp’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-136,891	Closed	-$5.99M	–	215
2021 Q1	$5.99M	Sell	136,891 -5,146	-4%	-$241K	0.79%	59
2020 Q4	$6.52M	Sell	142,037 -28,888	-17%	-$1.2M	1%	31
2020 Q3	$5.68M	Buy	170,925 +52,174	+44%	+$1.67M	0.98%	34
2020 Q2	$3.49M	Buy	118,751 +31,560	+36%	+$914K	0.62%	73
2020 Q1	$2.35M	Buy	+87,191	New	+$2.6M	0.47%	90
2018 Q4	–	Sell	-206,492	Closed	-$14.1M	–	344
2018 Q3	$14.1M	Sell	206,492 -3,884	-2%	-$250K	1.24%	14
2018 Q2	$12M	Sell	210,376 -2,037	-1%	-$108K	1.04%	29
2018 Q1	$9.79M	Sell	212,413 -12,054	-5%	-$572K	0.88%	46
2017 Q4	$10.4M	Sell	224,467 -9,109	-4%	-$419K	0.87%	53
2017 Q3	$11K	Buy	+233,576	New	+$9.97M	0.92%	41

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Phocas Financial Corp's AVNS Position: Q2 2021 in Review

Phocas Financial Corp sold out of Avanos Medical (AVNS) in Q2 2021, closing a stake of 136,891 shares — an estimated $5.99M sold.

Phocas Financial Corp first reported a position in AVNS in Q3 2017 and held it in 10 quarters. The position peaked at $14.1M in Q3 2018. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2021.

Phocas Financial Corp reported no remaining Avanos Medical position as of Q2 2021 after selling out during the quarter.
Phocas Financial Corp sold 136,891 Avanos Medical shares in Q2 2021, an estimated $5.99M.
Phocas Financial Corp first reported a position in Avanos Medical in Q3 2017 and held it in 10 quarters.
Phocas Financial Corp's Avanos Medical position peaked at $14.1M in Q3 2018.
274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2021.

Based on Phocas Financial Corp's 13F filing for Q2 2021, filed 16 Aug 2021.